v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash and Cash Equivalents $ 5,508,899 $ 3,792,322
Short-Term Investments 13,866,546 22,999,760
Prepaid Expenses and Other Current Assets 650,429 2,042,487
Collaboration Receivables 1,213,226 601,197
Tax and Other Receivables 1,454,756 270,246
Total Current Assets 22,693,856 29,706,012
Non-Current Assets:    
Property and Equipment, Net 101,807 5,232
Restricted Cash 4,520 4,057
Intangible Assets and In-Process R&D, Net 6,687,100 6,687,100
Operating Lease Right-of-Use Assets 318,036 57,170
Other Assets 58,135 24,913
Total Assets 29,863,454 36,484,484
Current Liabilities:    
Accounts Payable 241,471 415,590
Accrued Expenses 2,153,906 4,588,657
Accrued Collaboration Credit 29,057 981,111
Operating Lease Liabilities 155,926 23,355
Total Current Liabilities 2,580,360 6,008,713
Non-Current Liabilities:    
Contingent Consideration 2,883,423 4,191,490
Deferred Tax Liability 490,690 490,690
Deferred Collaboration Revenue 1,250,000 0
Non-Current Operating Lease Liabilities 248,239 33,815
Total Non-Current Liabilities 4,872,352 4,715,995
Total Liabilities 7,452,712 10,724,708
Commitments and Contingencies (Note 10)
Stockholders’ Equity:    
Preferred Stock, $0.01 Par Value: 10,000,000 shares authorized; 3,750 designated Series A, 0 shares issued and outstanding; 10,000 designated Series B, 0 shares issued and outstanding; 10,000 shares designated Series C, 0 shares issued and outstanding; 20,000 shares designated Series D, 7 shares issued and outstanding; 1,280 shares designated Series E, 0 shares issued and outstanding; 3,908 shares designated Series F, 420 issued and outstanding at September 30, 2025 and December 31, 2024, respectively 4 4
Common Stock, $0.01 Par Value: 150,000,000 shares authorized; 3,433,491 and 3,000,788 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 272,006 267,679
Additional Paid-In Capital 170,083,195 169,156,374
Accumulated Deficit (147,700,755) (143,382,122)
Accumulated Other Comprehensive Loss (243,708) (282,159)
Total Stockholders’ Equity 22,410,742 25,759,776
Total Liabilities and Stockholders’ Equity $ 29,863,454 $ 36,484,484

Source

10-Q PDF XBRL Zip